KBG syndrome. Sequencing of the ANKRD11 gene by Sanger [1 gene]

Patients with clinical suspicion of KBG syndrome.

Request study Informed consent
Steps to follow
Steps to follow

How to order

1. Download & fill out

Please cover as many fields as possible in both documents

2. Sample collection

Three sample types: saliva, peripheral blood or genomic DNA

3. Pack the sample

Please pack the sample in a way to prevent leakage

4. Send the sample & the request

Please schedule the delivery for Monday–Friday: 8am – 5pm

5. Result: the report

Via: e-mail and/or through the customer portal

Ask for information
Solicita información de

KBG syndrome. Sequencing of the ANKRD11 gene by Sanger

"*" indicates required fields

Consentimiento*
This field is for validation purposes and should be left unchanged.
Technique: Sanger

Turnaround time (TAT): 25 days

Ref. S-202009388

KBG syndrome. Sequencing of the ANKRD11 gene by Sanger: View panel
  • ANKRD11

Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.